Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Methotrexate sometimes helps regrow hair in children with severe alopecia areata and is generally safe.

Stress might contribute to hair loss in alopecia areata.

Adalimumab may cause severe hair loss in some patients.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Baricitinib is effective and safe for treating severe alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Guidelines help design better trials to compare alopecia areata treatments.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

Corticosteroid treatment reduces inflammation and alters hair keratins in alopecia areata.

Zinc supplements increased zinc levels in some hair loss patients but didn't significantly improve hair growth.

Twice-weekly 5 mg dexamethasone can effectively treat extensive alopecia areata in many patients.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

The pulsed infrared diode laser is effective for treating hair loss in alopecia areata.

Topical PUVA can cause temporary hair regrowth in some alopecia areata patients but doesn't change the long-term outcome.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Alopecia areata patients have higher oxidative stress and lower antioxidant levels.

Sulfasalazine may help regrow hair in severe alopecia areata cases.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Garlic gel with betamethasone cream significantly improves hair regrowth in alopecia areata.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Intralesional steroid injections are safe and effective for treating severe alopecia areata.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Both mouse and rat models are effective for testing alopecia areata treatments.